The move sees Paolo Morelli move into the role of Chairman for CROS NT allowing him to dedicate more time to PMH the holding company which oversees other life science businesses including ARITHMOS, its technology arm.
CROS NT Announces Appointment of Andrew MacGarvey as CEO
The move sees Paolo Morelli move into the role of Chairman for CROS NT allowing him to dedicate more time to PMH the holding company which oversees other life science businesses including ARITHMOS, its technology arm.
Tags
Related posts
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
- CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines
- Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
- New UK report highlights inequalities among people living with breast cancer
- ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery
